Dr Reddy's Laboratories, a Rs. 14,800 crore plus pharma giant from Hyderabad, has posted strong growth in bottomline during the year ended March 2019 despite pressure on top line. The consolidated net profit went up sharply by 106 per cent to Rs. 1,950 crore from Rs. 947 crore and its basic earnings per share improved to Rs. 117.53 from Rs. 57.08 in the last year. Though the margins improved, the DRL scrip received setback after the announcement of financial working and declined sharply by over 5.8 per cent to Rs. 2,588 on BSE on May 20, 2019 with market capitalization of Rs. 44,194 crore. The scrip touched to its yearly high level at Rs. 2,965 on May 2, 2019 as it started moving from yearly lowest level of Rs. 1,888 on May 21, 2018
Mylan Lab’s Generic Paricalcitol Receives Approval In US
Akorn’s Generic Paricalcitol Receives Approval In US
Amneal Pharm’s Generic Paricalcitol Receives Approval In US
Dr Reddy's Laboratories announced on Wednesday that it has entered into a strategic collaboration with Hyderabad-based Gland Pharma to market and distribute a diverse portfolio of eight injectable Abbreviated New Drug Applications (ANDAs), or alternatively called as generic drug approvals.
Teva ($TEVA) is recalling nearly 43,000 bottles of paricalcitol, a drug used by dialysis patients. But in this case, Teva didn’t manufacture them. They were produced by Pharmaceutics International Inc., or Pii, a U.S. CMO that recently ran into problems with European regulators.
Marksans Pharma has received approval from the US health regulator for Paricalcitol capsules, used for treating hyper parathyroidism.nn“US FDA has granted approval for an abbreviated new drug application (ANDA) for Paricalcitol Capsules 1 mcg, 2 mcg and 4 mcg,” Marksans Pharma said in a BSE filing.nnParicalcitol capsules are therapeutically equivalent to the reference listed drug Zemplar Capsules 1 mcg, 2 mcg and 4 mcg.nnParicalcitol capsules is a synthetic Vitamin D analog.nn“Vitamin D is important for absorption of calcium from the stomach and for functioning of calcium in the body. Paricalcitol is used to treat or prevent hyper parathyroidism,” the company said.
Dr Reddys Labs Ltd Generic Paricalcitol Approved in US
Dr. Reddy`s Laboratories, Inc. recalls lots of Paricalcitol Capsules due to Failed Tablet/Capsule Specifications
Lotus Pharm`s Generic Paricalcitol approved in US for treatment of secondary hyperparathyroidism